Rapid effect of single-dose rosiglitazone treatment on endothelial function in healthy men with normal glucose tolerance: data from a randomised, placebo-controlled, double-blind study.

Abstract:

:Antidiabetic thiazolidinediones (TZDs) improve endothelial function in patients with or without type 2 diabetes. The present randomised, placebo-controlled, double-blind study examined the time course of a single dose of rosiglitazone on flow-mediated endothelium-dependent vasodilation (FMD), metabolic parameters, and its effect on inflammatory markers in non-diabetic men. Forty non-obese, healthy men with normal glucose tolerance were randomised to a single dose of rosiglitazone (8 mg) or placebo, and FMD was assessed at baseline as well as after 6 h and 24 h. Rosiglitazone did not significantly affect blood glucose and insulin levels or lipid parameters after 6 and 24 h compared with placebo. Treatment with rosiglitazone significantly increased FMD after 6 h from 4.3% (3.3; 4.9) to 7.6% (5.6; 9.2) (p<0.0001 vs. baseline) resulting in a highly significant effect compared with placebo (p<0.0001 for difference between groups). After 24 h FMD was still significantly higher in the rosiglitazone group compared with baseline (p=0.001), but the effect was no longer statistically significant versus placebo (p=0.171). Our study shows a very rapid effect of single dose rosiglitazone treatment on endothelial function in non-diabetic healthy men, underscoring the hypothesis that TZDs may exhibit direct effect in the vasculature independent of their metabolic action.

journal_name

Diab Vasc Dis Res

authors

Walcher T,Walcher D,Hetzel J,Mielke C,Rau M,Rittig K,Balletshofer B,Schwedhelm E,Hombach V,Böger RH,Koenig W,Marx N

doi

10.1177/1479164110367812

subject

Has Abstract

pub_date

2010-07-01 00:00:00

pages

178-85

issue

3

eissn

1479-1641

issn

1752-8984

pii

1479164110367812

journal_volume

7

pub_type

杂志文章,随机对照试验
  • Combination of the dipeptidyl peptidase-4 inhibitor linagliptin with insulin-based regimens in type 2 diabetes and chronic kidney disease.

    abstract::Glucose-lowering treatment options for type 2 diabetes mellitus patients with chronic kidney disease are limited. We evaluated the potential for linagliptin in combination with insulin in type 2 diabetes mellitus patients with mild-to-severe renal impairment. Data for participants in two phase 3 trials with linaglipti...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/1479164115579001

    authors: McGill JB,Yki-Järvinen H,Crowe S,Woerle HJ,von Eynatten M

    更新日期:2015-07-01 00:00:00

  • Sub-optimal achievement of guideline-derived lipid goals in management of diabetes patients with atherosclerotic cardiovascular disease, despite high use of evidence-based therapies.

    abstract::Guidelines recommend aggressive goals for lipid and blood pressure reduction for high risk patients with diabetes mellitus and atherosclerotic coronary disease. However, it remains unclear how many patients achieve treatment goals versus the number of people merely placed on treatment. We conducted an observational st...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164111431471

    authors: DeGuzman PB,Akosah KO,Simpson AG,Barbieri KE,Megginson GC,Goldberg RI,Beller GA

    更新日期:2012-04-01 00:00:00

  • Volumes of coronary plaque disease in relation to body mass index, waist circumference, truncal fat mass and epicardial adipose tissue in patients with type 2 diabetes mellitus and controls.

    abstract:OBJECTIVES:Coronary atherosclerosis in patients with type 2 diabetes mellitus may be promoted by regional fat distribution. We investigated the association between anthropometric measures of obesity, truncal fat mass, epicardial adipose tissue and coronary atherosclerosis in asymptomatic patients and matched controls. ...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164119825761

    authors: Gullaksen S,Funck KL,Laugesen E,Hansen TK,Dey D,Poulsen PL

    更新日期:2019-07-01 00:00:00

  • Platelet abnormalities in diabetes mellitus.

    abstract::Patients with diabetes mellitus (DM) have accelerated atherosclerosis, which is the main underlying factor contributing to the high risk of atherothrombotic events in these patients. Atherothrombotic complications are the leading cause of morbidity and mortality in patients with DM. Among factors contributing to the p...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.1177/1479164110383994

    authors: Ferreiro JL,Gómez-Hospital JA,Angiolillo DJ

    更新日期:2010-10-01 00:00:00

  • Atherosclerosis in type 2 diabetes: a role for fibrate therapy?

    abstract::Vascular complications associated with type 2 diabetes confer significant morbidity and mortality. Atherosclerosis develops much earlier and progresses more rapidly than in subjects without diabetes. The clustering of cardiovascular risk factors associated with type 2 diabetes is mainly responsible for accelerated ath...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.3132/dvdr.2007.067

    authors: Steiner G

    更新日期:2007-12-01 00:00:00

  • Raised natriuretic peptides, big-endothelin-1 and improved beta-cell function in type 2 diabetic males with hyperuricaemia.

    abstract::Urate, a naturally-occurring antioxidant, is a marker/factor for cardiovascular disease. Hyperuricaemia is associated with IR, MetS and endothelial dysfunction. We characterised the associations between neurohormones, uricaemia, and glucose homeostasis in type 2 diabetes mellitus (T2DM) males. Cross-sectional; 705 T2D...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164109336689

    authors: Hermans MP,Ahn SA,Rousseau MF

    更新日期:2009-07-01 00:00:00

  • Telmisartan reverses antiretroviral-induced adipocyte toxicity and insulin resistance in vitro.

    abstract:BACKGROUND:Antiretroviral therapy in HIV-positive patients leads to insulin resistance which is central to the pathogenesis of various metabolic abnormalities and cardiovascular disease seen in this patient group. We have investigated the dose-response relationship of telmisartan, an antihypertensive, on adipocytes in ...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164118757924

    authors: Pushpakom SP,Adaikalakoteswari A,Owen A,Back DJ,Tripathi G,Kumar S,McTernan P,Pirmohamed M

    更新日期:2018-05-01 00:00:00

  • Impaired response to exercise intervention in the vasculature in metabolic syndrome.

    abstract::Physical activity decreases risk for diabetes and cardiovascular disease morbidity and mortality; however, the specific impact of exercise on the diabetic vasculature is unexamined. We hypothesized that an acute, moderate exercise intervention in diabetic and hypertensive rats would induce mitochondrial biogenesis and...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164112459664

    authors: Knaub LA,McCune S,Chicco AJ,Miller M,Moore RL,Birdsey N,Lloyd MI,Villarreal J,Keller AC,Watson PA,Reusch JE

    更新日期:2013-05-01 00:00:00

  • High prevalence of elevated haemoglobin A1C among adolescent blood donors: Results from a voluntary screening programme including 31,546 adolescents.

    abstract::More than 1 in 10 US adolescents have prediabetes or diabetes, and elevated glycosylated haemoglobin (HbA1C) in youth is associated with increased risk of death before the age of 55 years. We conducted a prospective, cross-sectional study of 31,546 consecutive volunteer blood donors, 16-19 years of age, who donated bl...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164115579799

    authors: Gore MO,Eason SJ,Ayers CR,Turer AT,Khera A,de Lemos JA,McGuire DK,Sayers M

    更新日期:2015-07-01 00:00:00

  • Long non-coding RNA nuclear paraspeckle assembly transcript 1 inhibits the apoptosis of retina Müller cells after diabetic retinopathy through regulating miR-497/brain-derived neurotrophic factor axis.

    abstract:BACKGROUND:The role of long non-coding RNA in diabetic retinopathy, a serious complication of diabetes mellitus, has attracted increasing attention in recent years. The purpose of this study was to explore whether long non-coding RNA nuclear paraspeckle assembly transcript 1 was involved in the context of diabetic reti...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164117749382

    authors: Li XJ

    更新日期:2018-05-01 00:00:00

  • Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort.

    abstract:OBJECTIVE:To characterize copeptin levels and to explore its prognostic importance in patients with acute myocardial infarction with newly detected glucose abnormalities. METHODS:Copeptin was measured in 166 patients with acute myocardial infarction without known diabetes and in 168 age- and gender-matched controls. P...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,多中心研究

    doi:10.1177/1479164116664490

    authors: Smaradottir MI,Ritsinger V,Gyberg V,Norhammar A,Näsman P,Mellbin LG

    更新日期:2017-03-01 00:00:00

  • Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis.

    abstract:OBJECTIVE:Statins are extensively used for lowering LDL-cholesterol and reducing cardiovascular events. Recent studies have shown that statins have beneficial anti-inflammatory effects. We aimed to determine whether and how adipokines are regulated during statin treatment in type 2 diabetic patients. METHOD:In this st...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/1479164109339966

    authors: Hu Y,Tong G,Xu W,Pan J,Ryan K,Yang R,Shuldiner AR,Gong DW,Zhu D

    更新日期:2009-10-01 00:00:00

  • Increased circulating levels of musclin in newly diagnosed type 2 diabetic patients.

    abstract:BACKGROUND:Musclin is a newly identified skeletal muscle-derived secretory factor, which has been recently characterized as a stimulator that induces insulin resistance in mice. However, the pathophysiological role of musclin in humans remains poorly understood. The aim of this study was to explore the potential correl...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164116675493

    authors: Chen WJ,Liu Y,Sui YB,Zhang B,Zhang XH,Yin XH

    更新日期:2017-03-01 00:00:00

  • Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases.

    abstract::Chronic diseases account for approximately 45% of all deaths in developed countries and are particularly prevalent in countries with the most sophisticated and robust public health systems. Chronic metabolic diseases, specifically lifestyle-related diseases pertaining to diet and exercise, continue to be difficult to ...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.1177/1479164117738442

    authors: Ackers I,Malgor R

    更新日期:2018-01-01 00:00:00

  • Description of Doppler waveforms to detect lower extremity peripheral artery disease.

    abstract::Doppler waveforms analysis is a interesting to diagnose peripheral artery disease as suggested by the international recommendations. However as mentioned in the present letter, there is a lack of consensus about the terminology that should be used. ...

    journal_title:Diabetes & vascular disease research

    pub_type: 评论,信件

    doi:10.1177/1479164118809527

    authors: Lanéelle D,Stivalet O,Mahé G,Jaquinandi V,Omarjee L

    更新日期:2019-01-01 00:00:00

  • The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).

    abstract::The objective of this study was to evaluate the safety and tolerability of atorvastatin 10 mg compared with placebo in 2,838 patients with type 2 diabetes and no history of coronary heart disease who were enrolled in the Collaborative Atorvastatin Diabetes Study (CARDS) and followed for 3.9 years. The percentages of p...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.3132/dvdr.2008.029

    authors: Newman CB,Szarek M,Colhoun HM,Betteridge DJ,Durrington PN,Hitman GA,Neil HA,Demicco DA,Auster S,Fuller JH,Cards Investigators.

    更新日期:2008-09-01 00:00:00

  • Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register.

    abstract:OBJECTIVES:Assess the effect of risk factors changes on risk for cardiovascular disease and mortality in patients with type 2 diabetes selected from the Swedish National Diabetes Register. METHODS:Observational study of 13,477 females and males aged 30-75 years, with baseline HbA1c 41-67 mmol/mol, systolic blood press...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164116637311

    authors: Eeg-Olofsson K,Zethelius B,Gudbjörnsdottir S,Eliasson B,Svensson AM,Cederholm J

    更新日期:2016-07-01 00:00:00

  • Physical activity for the prevention and management of youth-onset type 2 diabetes mellitus: focus on cardiovascular complications.

    abstract::With the growing prevalence of childhood obesity and type 2 diabetes mellitus (T2DM) in youth, the challenge of cardiovascular disease risk management has entered the paediatric realm, affecting specialists, family physicians and allied healthcare professionals alike. Currently, there is little evidence to support opt...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.3132/dvdr.2007.057

    authors: McGavock J,Sellers E,Dean H

    更新日期:2007-12-01 00:00:00

  • The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO).

    abstract::Telmisartan partially activates the peroxisome proliferator-activated receptor γ (PPARγ), which may ameliorate the accumulation of visceral adipose tissues and sensitise insulin action. Nineteen patients with essential hypertension and metabolic syndrome were randomly assigned to receive 40 mg of telmisartan (TELMI gr...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/1479164112444640

    authors: Murakami K,Wada J,Ogawa D,Horiguchi CS,Miyoshi T,Sasaki M,Uchida HA,Nakamura Y,Makino H

    更新日期:2013-01-01 00:00:00

  • Ethnic differences in beta-cell function, dietary intake and expression of the metabolic syndrome among UK adults of South Asian, black African-Caribbean and white-European origin at high risk of metabolic syndrome.

    abstract::A cross-sectional analysis of ethnic differences in dietary intake, insulin sensitivity and beta-cell function, using the intravenous glucose tolerance test (IVGTT), was conducted on 497 healthy adult participants of the 'Reading, Imperial, Surrey, Cambridge, and Kings' (RISCK) study. Insulin sensitivity (Si) was sign...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164112467545

    authors: Goff LM,Griffin BA,Lovegrove JA,Sanders TA,Jebb SA,Bluck LJ,Frost GS,RISCK Study Group.

    更新日期:2013-07-01 00:00:00

  • Effect of 12-month intervention with low-dose atorvastatin on pulse wave velocity in subjects with type 2 diabetes and dyslipidaemia.

    abstract::Cardiovascular disease is the leading cause of morbidity and mortality in subjects with type 2 diabetes mellitus. Increased aortic stiffness, assessed with the carotid-femoral pulse wave velocity, is an independent risk factor for cardiovascular disease. Statins reduce effectively cardiovascular disease and mortality ...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164118805320

    authors: Grigoropoulou P,Tentolouris A,Eleftheriadou I,Tsilingiris D,Vlachopoulos C,Sykara M,Tentolouris N

    更新日期:2019-01-01 00:00:00

  • Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studies.

    abstract::We conducted a meta-analysis of cohort and case-control studies to evaluate all-cause and cardiovascular (CV) mortality of patients with type 2 diabetes mellitus (T2DM) who received sulphonylurea (SU) treatment, when compared to any other diabetes treatment. Only studies reporting raw data on mortality during SU treat...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,meta分析,评审

    doi:10.1177/1479164112465442

    authors: Forst T,Hanefeld M,Jacob S,Moeser G,Schwenk G,Pfützner A,Haupt A

    更新日期:2013-07-01 00:00:00

  • Pre-diabetes, diabetes and predictors of incident angina among older women and men in the Cardiovascular Health Study.

    abstract::Diabetes mellitus and angina pectoris are important conditions in older persons. The utility of pre-diabetes mellitus, diabetes mellitus and other risk factors as predictors of incident angina pectoris among older adults has not been characterized. We examined incident angina pectoris rates by sex and diabetes mellitu...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,多中心研究

    doi:10.1177/1479164119888476

    authors: Mathenge N,Fan W,Wong ND,Hirsch C,Delaney CJ,Amsterdam EA,Koch B,Calara R,Gardin JM

    更新日期:2020-01-01 00:00:00

  • Elevated levels of insulin-like growth factor-binding protein 1 predict outcome after acute myocardial infarction: A long-term follow-up of the glucose tolerance in patients with acute myocardial infarction (GAMI) cohort.

    abstract:OBJECTIVE:To investigate the long-term prognostic value of insulin-like growth factor-binding protein 1 in patients with acute myocardial infarction. METHODS:Patients ( n = 180) with admission glucose < 11 mmol/L without previously known diabetes admitted for an acute myocardial infarction in 1998-2000 were followed f...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164118781892

    authors: Ritsinger V,Brismar K,Mellbin L,Näsman P,Rydén L,Söderberg S,Norhammar A

    更新日期:2018-09-01 00:00:00

  • Association between interarm blood pressure differences and diabetic retinopathy in patients with type 2 diabetes.

    abstract:BACKGROUND:The effect of interarm blood pressure difference on the development of diabetic retinopathy, proteinuria and chronic kidney disease remains unknown. We investigated to determine the impact of interarm blood pressure difference on the prevalence of diabetic retinopathy, proteinuria and chronic kidney disease ...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164120945910

    authors: Lee JH,Kim YA,Lee Y,Bang WD,Seo JH

    更新日期:2020-07-01 00:00:00

  • Insulin resistance: Impact on therapeutic developments in diabetes.

    abstract::Insulin resistance has a broad pathogenic impact affecting metabolic, cardio-renal and other disease areas. Extensive studies to dissect the mechanisms of insulin resistance have provided valuable insights to shape current clinical awareness and advance therapeutic practice. However, the development of direct interven...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.1177/1479164119827570

    authors: Bailey CJ

    更新日期:2019-03-01 00:00:00

  • Assessment of structural cardiac abnormalities and diastolic function in women with gestational diabetes mellitus.

    abstract:BACKGROUND:The main manifestation of hyperglycaemia during pregnancy is gestational diabetes mellitus. It can herald diabetes mellitus type 2 and its deleterious long-term effects, such as hypertension and cardiovascular disease. The aim of this study was to assess diastolic function in women with gestational diabetes ...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164114563302

    authors: Oliveira AP,Calderon IM,Costa RA,Roscani MG,Magalhães CG,Borges VT

    更新日期:2015-05-01 00:00:00

  • The combination of OLmesartan and a CAlcium channel blocker (azelnidipine) or candesartan and a calcium channel blocker (amlodipine) in type 2 diabetic hypertensive patients: the OLCA study.

    abstract::Angiotensin II receptor blockers (ARB) are often co-administered with a calcium channel blocker (CCB) for treating hypertension. In this open-label randomised study, untreated diabetic hypertensive patients were randomised to receive either olmesartan 20 mg/day or candesartan 8 mg/day for 12 weeks. Patients with blood...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/1479164112447310

    authors: Daikuhara H,Kikuchi F,Ishida T

    更新日期:2012-10-01 00:00:00

  • Prevalence of metabolic syndrome in young patients with acute MI: does the Framingham Risk Score underestimate cardiovascular risk in this population?

    abstract::To assess the prevalence of metabolic syndrome (MS) and estimates of global risk by Framingham Risk Score in young subjects with acute myocardial infarction (MI), we assessed metabolic parameters and global risk assessment in 165 consecutive subjects who presented with myocardial infarction prior to 45 years of age. N...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.3132/dvdr.2006.012

    authors: Zarich S,Luciano C,Hulford J,Abdullah A

    更新日期:2006-09-01 00:00:00

  • Non-LDL-related dyslipidaemia and coronary risk: a case-control study.

    abstract::To assess the non-LDL-C-related dyslipidaemia risk of MI, 823 men aged 23 to 65 with a first MI were compared with 823 MI-free PROCAM controls matched for sex, age, smoking, DM, BP and LDL-C. Overall, the odds of MI in men with HDL-C < 1.15 mmol/L were 2.6 times those of men with HDL-C >or= 1.15 mmol/L, and the odds o...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164110372640

    authors: Assmann G,Cullen P,Schulte H

    更新日期:2010-07-01 00:00:00